Transforming Growth Factor-β Modulates Plasminogen Activator Activity and Plasminogen Activator Inhibitor Type-1 Expression in Human Keratinocytes In Vitro
- 1 November 1990
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 95 (5), 607-613
- https://doi.org/10.1111/1523-1747.ep12505603
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cyclophilin Content of Normal and Psoriatic EpidermisJournal of Investigative Dermatology, 1990
- Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental‐type PAI‐2FEBS Letters, 1988
- Detection of both type 1 and type 2 plasminogen activator inhibitors in human cellsJournal of Cellular Physiology, 1988
- Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.The Journal of cell biology, 1987
- Some recent advances in the chemistry and biology of transforming growth factor-beta.The Journal of cell biology, 1987
- Migrating Keratinocytes Express Urokinase-Type Plasminogen ActivatorJournal of Investigative Dermatology, 1987
- Human Keratinocytes Synthesize and Secrete the Extracellular Matrix Protein, ThrombospondinJournal of Investigative Dermatology, 1987
- Bacterial lipopolysaccharide suppresses the production of catalytically active lysosomal acid hydrolases in human macrophages.The Journal of cell biology, 1986
- Human keratinocytes that have not terminally differentiated synthesize laminin and fibronectin but deposit only fibronectin in the pericellular matrixJournal of Cellular Biochemistry, 1985
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970